Is all research essential? Nope. Miguel Tovar/University of Houston

Many researchers have begun to work from home due to the novel COVID-19 pandemic, and only essential personnel are allowed to work on university campuses. For a researcher, what is considered "essential personnel"? Isn't all research essential to the workings of a public research university?

In a word, no.

As much as one would like to believe their respective job is of the utmost importance to human existence, certain mitigating factors can overrule that sensibility – and the definition of the word "essential" – in a moment's time. According to an article in Inside Higher Education, a Ph.D. candidate researching diabetes at the University of Toronto said, "There is no single experiment or laboratory activity that is more important than saving the life of even a single individual in the community."

Your university or institution may not have closed completely, yet it is safe to suspect that you have been asked to complete most of your work remotely. With most counties in the nation declaring a shelter in place order, researchers who have been required to "ramp down" lab activities may be feeling extreme disappointment and even panic.

Allowances and exceptions for federally funded research

The NSF has extended deadlines for some applications and reports. For instance, it has extended the dates of all annual project reports due between March 1 and April 30 by 30 days. In addition, the charge of costs or fees that have been incurred due to COVID-19 can be negotiated, as long as there is proper documentation and the result is not a shortage of funds to eventually carry out the project.

The NIH released NOT-OD-20-086 on March 12, 2020 to alert the research community of certain flexibilities which apply to NIH applicants and recipients. Some of these include pre-award costs, extension of required reporting, prior approval waivers and expenditure of award funds – especially involving travel. There are other exceptions being made, including allowing salaries to be charged against grant monies in some instances.

So, you have to go to campus

If you are a researcher who ensures the continuity of key operations, such as an animal care operations worker, there are several things you can do to keep yourself and your colleagues safe, which will come as no

surprise:

  1. Very few researchers are allowed on campus. If you are working on campus, keep 6 feet away from your co-workers. There should be a greatly reduced number of researchers in the lab or facility at any given time.
  2. Wash your hands. Follow all environmental safety and hazardous material rules to a tee.
  3. Be careful when getting deliveries and regularly clean your workspace.
  4. Research the many funding opportunities that are available to contribute to the solution of COVID-19 related issues.

Just breathe…it’s going to be okay

If this pandemic has taught us anything, it is that an emergency plan is the best bet for staving off panic and flowing as seamlessly as possible into a remote working situation. As always, safety is goal one and this situation's trajectory is causing safety concerns to escalate. Your research will ramp up again, make no mistake, although for the time being it may have fallen victim to this outbreak. If you stay in close adherence to policies put forth by your institution and you keep your sponsor abreast of your next steps, all will work out in the end.

------

This article originally appeared on the University of Houston's The Big Idea.

Sarah Hill is the communications manager for the UH Division of Research.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.